We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+0.05%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$3.55B
AUM Growth
+$59.4M
Cap. Flow
-$31.8M
Cap. Flow %
-0.9%
Top 10 Hldgs %
49.57%
Holding
665
New
156
Increased
155
Reduced
111
Closed
128
Avg Time Held Equity + Options
3.9 quarters
Top 10 Avg Time Held Equity + Options
0.8 quarters
Top 20 Avg Time Held Equity + Options
1.2 quarters
Avg Time Held Equity only
4.3 quarters
Top 10 Avg Time Held Equity only
0.8 quarters
Top 20 Avg Time Held Equity only
1.2 quarters

Sector Composition

Rank Sector Weight
1 Energy 26.53%
2 Technology 21.03%
3 Healthcare 14.68%
4 Industrials 8.19%
5 Miscellaneous 6.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
AAPL icon
526
CALL
Apple
AAPL
$4.91T
– –
-50,000
Closed -$169K –
AAPL icon
527
PUT
Apple
AAPL
$4.91T
– –
-50,000
Closed -$220K –
ADBE icon
528
Adobe
ADBE
$94.3B
– –
-18,797
Closed -$9.48M –
AFMD icon
529
DELISTED
Affimed
AFMD
– –
-19,071
Closed -$101K –
AMCX icon
530
PUT
AMC Global Media
AMCX
$446M
– –
-50,000
Closed -$215K –
AMD icon
531
Advanced Micro Devices
AMD
$993B
– –
-9,624
Closed -$1.74M –
ANNX icon
532
CALL
Annexon
ANNX
$762M
– –
-418,500
Closed -$532K –
ATXS icon
533
PUT
DELISTED
Astria Therapeutics
ATXS
– –
-90,000
Closed -$13.5K –
AUTL icon
534
Autolus Therapeutics
AUTL
$482M
– –
-155,857
Closed -$994K –
AZN icon
535
AstraZeneca
AZN
$247B
– –
-27,142
Closed -$4.08M –
BA icon
536
CALL
Boeing
BA
$150B
– –
-20,000
Closed -$2.6K –
BALL icon
537
Ball Corp
BALL
$15.5B
– –
-94,840
Closed -$6.39M –
BCAB icon
538
DELISTED
BIOATLA INC
BCAB
– –
-4,195
Closed -$722K –
BCRX icon
539
BioCryst Pharmaceuticals
BCRX
$2.18B
– –
-32,630
Closed -$166K –
BCYC icon
540
CALL
Bicycle Therapeutics
BCYC
$272M
– –
-70,000
Closed -$130K –
BE icon
541
Bloom Energy
BE
$82.6B
– –
-250,000
Closed -$2.81M –
BHVN icon
542
CALL
Biohaven
BHVN
$1.82B
– –
-23,000
Closed -$110K –
BIDU icon
543
Baidu
BIDU
$29B
– –
-137,500
Closed -$14.5M –
BIIB icon
544
CALL
Biogen
BIIB
$33.3B
– –
-18,000
Closed -$33.3K –
BIIB icon
545
Biogen
BIIB
$33.3B
– –
-2,500
Closed -$539K –
BMBL icon
546
Bumble
BMBL
$335M
– –
-75,000
Closed -$851K –
CHGG icon
547
Chegg
CHGG
$81.7M
– –
-12,500
Closed -$94.6K –
COGT icon
548
Cogent Biosciences
COGT
$5.38B
– –
-22,442
Closed -$151K –
CPNG icon
549
Coupang
CPNG
$28.4B
– –
-30,000
Closed -$534K –
CRBP icon
550
Corbus Pharmaceuticals
CRBP
$104M
– –
-7,500
Closed -$294K –

Similar funds

UBS O'Connor's Q2 2024 Portfolio in Review

As of Q2 2024, UBS O'Connor held 665 positions worth $3.55B, up 1.7% from $3.49B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

UBS O'Connor's Q2 2024 filing shows 156 new, 155 increased, 111 reduced and 128 closed positions. Its largest new stake was Endeavor Group Holdings, Inc.: 4,789,930 shares worth $129M. The largest sale was Pioneer Natural Resource Co., an estimated $638M.

By sector, the portfolio is most concentrated in Energy at 27% of assets, down from 34% a quarter earlier, followed by Technology and Healthcare.

  • UBS O'Connor's largest Q2 2024 buy was Endeavor Group Holdings, Inc.: 4,789,930 shares worth $129M.
  • UBS O'Connor added most to HashiCorp, Inc. Class A Common Stock in Q2 2024, an estimated $138M increase.
  • UBS O'Connor's biggest Q2 2024 reduction was Cerevel Therapeutics Holdings, Inc. Common Stock, cutting an estimated $51.2M.
  • UBS O'Connor fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $638M.
  • UBS O'Connor's ten largest holdings make up 50% of its $3.55B portfolio in Q2 2024.
  • UBS O'Connor opened 156 new positions and closed 128 in Q2 2024.
  • UBS O'Connor's portfolio value rose 1.7% quarter-over-quarter to $3.55B.

Based on UBS O'Connor's 13F filing for Q2 2024, filed 14 Aug 2024.